Analyst Ratings for Iovanace Biotherapeutics (IOVA)
IOVA Rating Summary
IOVA Price Target Summary
- Highest: $13.00 (Barclays)
- Lowest: $4.00 (Baird)
- Average: $9.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$9.25 (+11.7%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$9.25 (+11.7%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/22/2026 | TD Cowen » Updated 8/25/2026 |
Nicholas Lorusso | New Coverage | Buy (N/A) |
10.00 (7.00) |
8.99 (8.28) |
-7.9% | Details |
| 2/25/2026 | Citizens » Updated 8/7/2026 |
Reni J. Benjamin | Upgrade | Market Outperform (Market Perform) |
8.00 (5.00) |
2.89 (8.28) |
186.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
